Lanlin Zhang
130 Dong An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
EZH2 inhibition overcomes immune evasion in lung adenocarcinoma by restoring CCL5-mediated T-cell recruitment and MHC class I antigen presentation.
Journal: Acta biochimica et biophysica Sinica
Published: March 03, 2026
A novel neoadjuvant therapy for early-stage non-small cell lung cancer in a mouse model.
Journal: Journal of thoracic disease
Published: October 06, 2023
A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity.
Journal: Journal of immunology research
Published: October 06, 2021
Development of a nomogram for preoperative prediction of lymph node metastasis in non-small cell lung cancer: a SEER-based study.
Journal: Journal of thoracic disease
Published: August 18, 2020
Transcription factor RUNX3 promotes CD8+ T cell recruitment by CCL3 and CCL20 in lung adenocarcinoma immune microenvironment.
Journal: Journal of cellular biochemistry
Published: June 04, 2019
REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression.
Journal: Journal of cancer research and clinical oncology
Published: March 28, 2019
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
Journal: Journal of translational medicine
Published: October 17, 2018
Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients.
Journal: Journal of cancer research and clinical oncology
Published: October 09, 2018
Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.
Journal: Journal of cancer research and clinical oncology
Published: April 05, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026